Archives

by in
Entry Author Date Location
Ambrx Grabs $24M Upfront in New Diabetes, Heart Failure Research Deal With Bristol-Myers 09/22/11 San Diego
Latest in Stroke-Prevention Saga: FDA Panel Backs Drug From J&J and Bayer 09/09/11 New York
Bristol-Pfizer Team on Alert as FDA Reviews Stroke-Prevention Drug From Rivals J&J and Bayer 09/08/11 New York
Amira’s Windfall Sale, Ardea Advances Gout Drug, Gov. Brown’s Jobs Plan Wins Biotech Support, & More San Diego Life Science News 09/08/11 San Diego
Amira Pharma on How it Beat the Odds, and Sold an Early Stage Drug to Bristol-Myers for $325M 09/07/11 San Diego
Dramatic Changes in Hepatitis C Treatment Expected to Continue 09/06/11 San Diego
Video: Seattle Genetics CEO Makes the Case for a $100K Cancer Drug 08/22/11 Seattle
Xconomist of the Week: Tony Coles’ Journey from Mass General Doctor to SF Biotech CEO 08/18/11 National
Gilead HIV Drug Gets FDA OK 08/10/11 San Francisco
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus 08/08/11 National
Bristol-Myers Acquires Amira Pharmaceuticals for $325 Million, Scoops Up Lung Drug 07/21/11 San Diego
Bristol Diabetes Drug Gets Thumbs-Down 07/20/11 New York
Ensemble Therapeutics Builds Super-Sized Library of Mid-Sized Drugs 07/19/11 Boston
Optivia Biotech Finds its Way to Profits, With a Little Help from Friends at the FDA 07/05/11 San Francisco
Bristol Churns Out Diabetes Data 06/27/11 New York
Bristol and Pfizer Get Boost from Apixaban Data 06/23/11 New York
Alder Gets $15M From Bristol 06/20/11 Seattle
Bristol-Myers Squibb Gets Thumbs-Up on Transplant Drug 06/16/11 New York
Aria Shows Drug Data at ASCO, Pfizer Supports Selecta, WPI Adds Big Pharma Partners, & More Boston-Area Life Sciences News 06/10/11 Boston
BMS & Others Partner with WPI 06/09/11 Boston
New York Area Companies Head to ASCO With High Hopes For Future Cancer Blockbusters 06/01/11 New York
Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer 05/24/11 Seattle
Pfizer and BMS Score Approval for Orthopedic Drug 05/20/11 New York
Miller Tabak Fund Manager Says Investors Are Ignoring the Upsides in Healthcare 05/20/11 New York
The ImClone Alumni: Where Are They Now? 04/07/11 New York
Xconomy’s New Frontier of Innovation: New York 04/05/11 New York
Dendreon Wins Medicare Coverage, Clarisonic Tops $100M in Sales, Sage Partners Up, & More Seattle-Area Life Sciences News 03/31/11 Seattle
Bigger Isn’t Better: It’s Time for Big Pharma to Break Up Into Little Pharma 03/28/11 National
Exelixis Bags $156M, Tethys Bets on Prevention, UCSF’s Delicate Dance With Industry, & More Bay Area Life Sciences News 03/11/11 San Francisco
Exelixis Pockets $156M in Stock Sale, Riding Wave of Prostate Cancer Drug Results 03/09/11 San Francisco
Page 3 of 8 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  2. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.